Cargando…

Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA

To face the COVID-19 pandemic, the need for fast and reliable diagnostic assays for the detection of SARS-CoV-2 is immense. We describe our laboratory experiences evaluating nine commercially available real-time RT-PCR assays. We found that assays differed considerably in performance and validation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eberle, Ute, Wimmer, Clara, Huber, Ingrid, Neubauer-Juric, Antonie, Valenza, Giuseppe, Ackermann, Nikolaus, Sing, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845288/ https://www.ncbi.nlm.nih.gov/pubmed/33512617 http://dx.doi.org/10.1007/s10096-021-04159-9

Ejemplares similares

Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS-CoV-2 spread prior to the first German case in January 2020
por: Eberle, Ute, et al.
Publicado: (2021)

Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany − Addendum
por: Woudenberg, Tom, et al.
Publicado: (2021)

Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP)
por: Mautner, Lena, et al.
Publicado: (2020)

Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020
por: Konrad, Regina, et al.
Publicado: (2020)

Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021
por: Flechsler, Jennifer, et al.
Publicado: (2022)

Weekly SARS-CoV-2 Sentinel Surveillance in Primary Schools, Kindergartens, and Nurseries, Germany, June‒November 2020
por: Hoch, Martin, et al.
Publicado: (2021)

A review of commercially available thrombin generation assays
por: Kintigh, Jeremy, et al.
Publicado: (2017)

In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)
por: Jungnick, Sabrina, et al.
Publicado: (2021)

Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home
por: Schulz, Claudia, et al.
Publicado: (2021)

Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany)
por: Heinzinger, Susanne, et al.
Publicado: (2021)

Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) – CORRIGENDUM
por: Heinzinger, Susanne, et al.
Publicado: (2022)

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Hashem, Anwar M., et al.
Publicado: (2020)

Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
por: Stone, Mars, et al.
Publicado: (2022)

Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
por: Nilsson, Anna Christine, et al.
Publicado: (2021)

Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina
por: Simionato, Laura D., et al.
Publicado: (2018)

Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays
por: Bachman, Christine M., et al.
Publicado: (2021)

Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
por: Murray, Matthew J., et al.
Publicado: (2021)

Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays
por: Johnson, Barbara W., et al.
Publicado: (2016)

Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories
por: Lieberman, Joshua A., et al.
Publicado: (2020)

Feasibility and Diagnostic Accuracy of Saliva-Based SARS-CoV-2 Screening in Educational Settings and Children Aged <12 Years
por: Hoch, Martin, et al.
Publicado: (2021)

Determining Vitamin D Status: A Comparison between Commercially Available Assays
por: Snellman, Greta, et al.
Publicado: (2010)

Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
por: Lin, Guan-Yu, et al.
Publicado: (2020)

In Vitro Assay of Translation Inhibition by Trichothecenes Using a Commercially Available System
por: Toyotome, Takahito, et al.
Publicado: (2021)

Head-to-Head Comparison of Nine Assays for the Detection of Anti-Echinococcus Antibodies: A Retrospective Evaluation
por: Mattwich, Carolina, et al.
Publicado: (2024)

Full genome sequence of bovine alphaherpesvirus 2 (BoHV-2)
por: Pfaff, Florian, et al.
Publicado: (2020)

Commercially available accelerators
por: Barbalat, Oscar
Publicado: (1996)

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
por: Zedan, Hadeel T., et al.
Publicado: (2022)

Analysis of seven SARS-CoV-2 rapid antigen tests in detecting omicron (B.1.1.529) versus delta (B.1.617.2) using cell culture supernatants and clinical specimens
por: Jungnick, Sabrina, et al.
Publicado: (2022)

SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay
por: Wollschläger, Paul, et al.
Publicado: (2021)

Correction: Determining Vitamin D Status: A Comparison between Commercially Available Assays
por: Snellman, Greta, et al.
Publicado: (2010)

Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples
por: Rath, Peter-Michael, et al.
Publicado: (2018)

Spectrophotometric-Based Assay to Quantify Relative Enzyme-Mediated Degradation of Commercially Available Bioplastics
por: Hoekstra, Matthew, et al.
Publicado: (2023)

Genetic diversity and delineation of Salmonella Agona outbreak strains by next generation sequencing, Bavaria, Germany, 1993 to 2018
por: Dangel, Alexandra, et al.
Publicado: (2019)

Validation of commercially available sphingosine kinase 2 antibodies for use in immunoblotting, immunoprecipitation and immunofluorescence
por: Neubauer, Heidi A., et al.
Publicado: (2017)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Diagnostic performances of four commercially available assays for the identification of SARS-CoV-2, influenza type A/B virus and RSV
por: Houwen, Cindy, et al.
Publicado: (2023)

Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay
por: Seegmiller, Jesse C., et al.
Publicado: (2020)

Occurrence of Nine Grapevine Viruses in Commercial Vineyards of Mendoza, Argentina
por: Gomez Talquenca, Sebastian, et al.
Publicado: (2023)

Risk Assessment of Nine Coccidiostats in Commercial and Home-Raised Eggs
por: Martins, Rui R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6it03shqjm1e1p10ehsb93qs99